Market Place
Sourcing Support
Novast`s Generics Mesalamine Receives Approval in US
22 Aug 2024 //
FDA
Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China
13 Jun 2024 //
PRESS RELEASE
Enforcement Report - Week of March 6, 2024
06 Mar 2024 //
FDA
Annora`s Generic Mesalamine Receives Approval in the U.S.
05 Feb 2024 //
FDA
AMTA` Generic Mesalamine Receives Approval in the U.S.
06 Jun 2023 //
FDA
Encube`s Generic Mesalamine Receives Receives Approval in the U.S.
30 May 2023 //
FDA
Alembic receives final approval from USFDA for generic Mesalamine ER capsules
01 Nov 2022 //
ECONOMICTIMES
Alembic`s Generic Mesalamine Receives Approval in the U.S.
28 Oct 2022 //
FDA
Sun Pharma announces US FDA approval for generic Mesalamine ER capsules
13 May 2022 //
EXPRESS PHARMA
Teva Pharmaceutical`s Generic Ritonavir Receives Approval in the U.S.
06 May 2022 //
FDA
Zydus Cadila receives US FDA approval for mesalamine ER capsules
14 Aug 2021 //
PHARMABIZ
Teva Announces Launch of its Generic Version of Canasa® (mesalamine)
23 Apr 2021 //
BIOSPACE
Teva Announces Launch of its Generic Version of Canasa® (mesalamine)
22 Apr 2021 //
BUSINESSWIRE
PharmaZell – Update on new Mesalazine production building in Vizag (India)
12 Jan 2021 //
PRESS RELEASE
Enforcement Report - Week of November 18, 2020
18 Nov 2020 //
FDA
Actavis`s Generic Mesalamine Receives Approval in US
22 Aug 2020 //
FDA
Lincoln Pharmaceuticals receives EU GMP approval
18 May 2020 //
EXPRESSPHARMA
Enforcement Report - Week of March 11, 2020
12 Mar 2020 //
FDA
Kyowa Kirin Announces Termination of Agreement with Zeria on ASACOL®
03 Feb 2020 //
PRESS RELEASE
Amneal Pharm`s Generic Mesalamine Receives Approval In Us
01 Jan 2020 //
FDA
Morton Grove`s Withdrawal of Approval of 21 Abbreviated New Drug Applications
02 Dec 2019 //
FEDERALREGISTER
Mylan`s Generic Mesalazine Receives Approval in US
21 Nov 2019 //
FDA
Amring Pharmaceuticals Announces the Launch of 2 Valued Pharmaceutical Generics
25 Jun 2019 //
BIOSPACE
Sandoz Inc.`s Generic Mesalazine Receives Approval in US
12 Jun 2019 //
FDA
Teva Pharms Generic Mesalamine Receives Approval in US
15 May 2019 //
FDA
Generic Version of Delzicol® Delayed-Release Capsules Launched in the US
10 May 2019 //
BUSINESSWIRE
NPPA fixes retail prices of 22 formulations under DPCO, 2013
06 May 2019 //
PHARMABIZ
Sun Pharm`s Generic Mesalamine Receives Approval in US
25 Jan 2019 //
FDA
Mylan Adds First Generic for Canasa® Rectal Suppository to Growing GE portfolio
18 Dec 2018 //
PR NEWSWIRE
Launch of Generic Lialda DR Tablets Expands Mylan`s GE Offering
18 Dec 2018 //
PR NEWSWIRE
Mylan Adds First Generic for Canasa® Rectal Suppository to Growing Gastroenterology Portfolio
18 Dec 2018 //
PR NEWSWIRE
Zydus Pharm`s Generic Mesalamine Receives Tentative Approval in US
29 Nov 2018 //
FDA
Zydus Pharms` Generic Mesalamine Receives Tentative Approval in US
29 Nov 2018 //
FDA
Pharma Sourcing Partners`s Generic Mesalamine Receives Approval in US
13 Nov 2018 //
FDA
Lack of blockbuster candidates at Takeda? Shire has it covered
01 Aug 2018 //
FIERCE PHARMA
Teva Pharms USA’s Generic Mesalamine Receives Tentative Approval In US
17 Jul 2018 //
FDA
Teva Announces the Launch of a Generic Version of Lialda® in the United States
26 Mar 2018 //
BUSINESSWIRE
FDA Says No180-Day Forfeiture for Generic LIALDA Based on Changed Bioequivalence
08 Mar 2018 //
FDALAWBLOG
Renaissance’s Generic Mesalamine Receives Approval In US
26 Aug 2017 //
FDA
Sandoz’s Generic Mesalamine Receives Tentative Approval In US
27 Jul 2017 //
FDA
Zydus Pharm’s Generic Mesalamine Receives Approval In US
21 Jul 2017 //
FDA
USFDA audit finds no flaws in Cadila Healthcare Moraiya unit
22 Jun 2017 //
BUSINESS-STANDARD
USFDA approves the generic version of Lialda of an Indian drug firm Zydus Cadila
15 Jun 2017 //
BIOSPECTRUM
Zydus Cadila gets USFDA nod for mesalamine tablets
06 Jun 2017 //
ECONOMIC TIMES
Maternal education fights malaria better than vaccine: Study
10 May 2017 //
ECONOMIC TIMES
Delzicol® (Mesalamine): Allergan & Qualicaps V. Teva Pharmaceuticals Usa
21 Apr 2017 //
PATENT LITIGATION
Allergan settles Delzicol patent litigation with Zydus & Cadila
02 Dec 2016 //
PHARMAIZB
Shire announces USPTO`s Patent Trial
06 Oct 2016 //
PHARMABIZ
Pectin-silica gels as matrices for controlled drug release
26 Sep 2016 //
PHARMA-EXCIPIENTS
Court rules in favour of Zydus` copy of Shire`s controlled-release UC drug
20 Sep 2016 //
IN-PHARMATECHNOLOGIST
Forest Labs Mesalamine Approved in US
07 Sep 2016 //
FDA
Tailoring the mucoadhesive and sustained release characteristics of mesalamine
08 Aug 2016 //
PHARMAEXCIPIENTS
Shire gets favorable ruling against Allergan in Lialda patent case
29 Mar 2016 //
REUTERS
Gastro-resistant multiparticles for mesalazine colonic delivery
10 Mar 2016 //
PHARMA-EXCIPIENTS
Lupin divest two products to G&W Laboratories at behest of USFTC – A Closer Look
23 Feb 2016 //
TWOFOUR INSIGHT
Mylan`s Generic Mesalamine approved in US to treat ulcerative colitis
24 Nov 2015 //
FDA
Mylan Confirms First-to-File Patent Challenge Relating to DELZICOL®
20 Nov 2015 //
PR NEWS WIRE
Mochida seeks Ulcerative Colitis drug approval in Japan
05 Nov 2015 //
BIOSPECTRUM ASIA
Cosmo Patent for Shire’s Lialda to Be Reviewed by Patent Office
08 Oct 2015 //
BLOOMBERG BUSINESS
Patent challenger Bass shrugs off Celgene`s attack on his short-selling motives
12 Aug 2015 //
FIERCE PHARMA
